| Recent advances in hydrogel based drug delivery systems for the human body A Vashist, A Vashist, YK Gupta, S Ahmad Journal of Materials Chemistry B 2 (2), 147-166, 2014 | 496 | 2014 |
| Advances in carbon nanotubes–hydrogel hybrids in nanomedicine for therapeutics A Vashist, A Kaushik, A Vashist, V Sagar, A Ghosal, YK Gupta, S Ahmad, ... Advanced healthcare materials 7 (9), 1701213, 2018 | 163 | 2018 |
| Nanogels as potential drug nanocarriers for CNS drug delivery A Vashist, A Kaushik, A Vashist, J Bala, R Nikkhah-Moshaie, V Sagar, ... Drug discovery today 23 (7), 1436-1443, 2018 | 116 | 2018 |
| Recent trends on hydrogel based drug delivery systems for infectious diseases A Vashist, A Kaushik, A Vashist, RD Jayant, A Tomitaka, S Ahmad, ... Biomaterials science 4 (11), 1535-1553, 2016 | 67 | 2016 |
| Appropriate DevR (DosR)-Mediated Signaling Determines Transcriptional Response, Hypoxic Viability and Virulence of Mycobacterium tuberculosis S De Majumdar, A Vashist, S Dhingra, R Gupta, A Singh, VK Challu, ... PLoS One 7 (4), e35847, 2012 | 53 | 2012 |
| Essentiality of DevR/DosR interaction with SigA for the dormancy survival program in Mycobacterium tuberculosis US Gautam, K Sikri, A Vashist, V Singh, JS Tyagi Journal of bacteriology 196 (4), 790-799, 2014 | 50 | 2014 |
| Bioresponsive injectable hydrogels for on-demand drug release and tissue engineering A Vashist, A Kaushik, K Alexis, R Dev Jayant, V Sagar, A Vashist, M Nair Current pharmaceutical design 23 (24), 3595-3602, 2017 | 44 | 2017 |
| Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs K Sikri, P Duggal, C Kumar, SD Batra, A Vashist, A Bhaskar, K Tripathi, ... Redox biology 15, 452-466, 2018 | 41 | 2018 |
| Phylogenetic network analysis revealed the occurrence of horizontal gene transfer of 16S rRNA in the genus Enterobacter M Sato, K Miyazaki Frontiers in microbiology 8, 302057, 2017 | 28* | 2017 |
| Development of multifunctional biopolymeric auto-fluorescent micro-and nanogels as a platform for biomedical applications A Vashist, V Atluri, A Raymond, A Kaushik, T Parira, Z Huang, A Durygin, ... Frontiers in Bioengineering and Biotechnology 8, 315, 2020 | 25 | 2020 |
| Interplay of PhoP and DevR response regulators defines expression of the dormancy regulon in virulent Mycobacterium tuberculosis A Vashist, V Malhotra, G Sharma, JS Tyagi, JE Clark-Curtiss Journal of Biological Chemistry 293 (42), 16413-16425, 2018 | 20 | 2018 |
| Co-Expression of DevR and DevRN-Aph Proteins Is Associated with Hypoxic Adaptation Defect and Virulence Attenuation of Mycobacterium tuberculosis SD Majumdar, D Sharma, A Vashist, K Kaur, NK Taneja, S Chauhan, ... PLoS One 5 (2), e9448, 2010 | 20 | 2010 |
| Journey of hydrogels to nanogels: a decade after A Vashist, A Kaushik, A Ghosal, R Nikkhah-Moshaie, A Vashist, ... | 17 | 2017 |
| Cognate sensor kinase‐independent activation of Mycobacterium tuberculosis response regulator DevR (DosR) by acetyl phosphate: implications in anti … S Sharma, P Kumari, A Vashist, C Kumar, M Nandi, JS Tyagi Molecular Microbiology 111 (5), 1182-1194, 2019 | 15 | 2019 |
| The α10 helix of DevR, the Mycobacterium tuberculosis dormancy response regulator, regulates its DNA binding and activity A Vashist, D Prithvi Raj, UD Gupta, R Bhat, JS Tyagi The FEBS journal 283 (7), 1286-1299, 2016 | 15 | 2016 |
| Mycobacterium tuberculosis PknK substrate profiling reveals essential transcription terminator protein rho and two-component response regulators PrrA and MtrA as novel targets … V Malhotra, BP Okon, AT Satsangi, S Das, UW Waturuocha, A Vashist, ... Microbiology Spectrum 10 (2), e01354-21, 2022 | 11 | 2022 |
| Recent advances in nanotherapeutics for neurological disorders A Vashist, P Manickam, AD Raymond, AY Arias, N Kolishetti, A Vashist, ... ACS Applied Bio Materials 6 (7), 2614-2621, 2023 | 8 | 2023 |
| Hydrogels: Stimuli responsive to on-demand drug delivery systems A Vashist, A Kaushik, RD Jayant, A Vashist, A Ghosal, M Nair Advances in personalized nanotherapeutics, 117-130, 2017 | 8 | 2017 |
| Impact of nanoclay on the pH-responsiveness and biodegradable behavior of biopolymer-based nanocomposite hydrogels A Vashist, A Ghosal, A Vashist, A Kaushik, YK Gupta, M Nair, S Ahmad Gels 5 (4), 44, 2019 | 7 | 2019 |
| Preliminary experience with yttrium-90-labelled rituximab (chimeric anti CD-20 antibody) in patients with relapsed and refractory B cell non-Hodgkins lymphoma P Thakral, S Singla, A Vashist, M P Yadav, S K Gupta, J S Tyagi, ... Current Radiopharmaceuticals 9 (2), 160-168, 2016 | 5 | 2016 |
Arti VashistDepartment of Immunology & Nanomedicine, (Prof. Madhavan Nair’s Laboratory),Herbert WertheimEmail confirmado em fiu.edu
